America's Permanent Collapse? 📉

Biotech is leading today's premarket gainers. Get a full report on all 4 top stocks inside [Image](www.elitetrade.club) Good Morning! Hey, guys and gals. It's Chris from Elite Trade Club, here to give you the day's premarket trading news. Happy Friday! It's September 9th. Let's get ready to trade! Markets 📈 The S&P 500 gained 0.7% on Thursday, while the Dow and Nasdaq added 0.6%/ The small-cap Russell 2K slightly outperformed its large-cap cohorts with a 0.8% gain. Today, stock futures are in the rise in early-morning trading. S&P 500 contracts are currently showing a 0.9% gain. Sponsored [America's Permanent Collapse?📉]( Former Goldman Sachs managing director, best-selling author, and Federal Reserve expert reveals to the public what's really happening in America. It's the hidden story, beyond: inflation, rent increases, gas, groceries, political division, or a pandemic... The exact reason the financial elite continue to get richer, grabbing more power while everyday folks struggle to live their daily lives. [Click Here For The FULL Story.]( Premarket Highlights 🔎 - European energy ministers have held emergency talks to discuss how to rein in soaring energy costs. Caps on Russian natural gas and producer revenues limits were both discussed as options. - The European Central Bank raised rates by 0.75% in its biggest rate hike in 23 years. What to Watch Today 👀 Slaying the Beast Markets rallied yesterday after key central bank leaders promised forceful action to tamp down inflation. Fed Chairman Jerome Powell said the central bank must act strongly to tame price pressures and to prevent the public from thinking of high inflation as the norm. Meanwhile, the European Central Bank announced its biggest cut in decades. Higher rates will undoubtedly slam the brakes on economic growth, but investors seem to be more worried about runaway inflation at the moment. These strong actions should provide some short-term reassurance to investors International 🌍 Asia Hong Kong's Hang Seng Composite rallied 2.7% overnight, while Australia's ASX 200 added 0.7% and China's Shanghai Composite advanced 0.8%. Europe European stocks are looking good midway through their trading session. The UK's FTSE 100 and German DAX are bother up 1.5%. The French CAC 40 is showing a 1.6% gain, and the Euro Stoxx 600 is up 1.6%. . Major Earnings 💰 The Kroger Co. [KR] ... AM Waterdrop [WDH] ... AM ABM Industries [ABM] ... AM IDEANOMICS [IDEX] ... AM Lesaka Technologies, Inc. [LSAK] ... PM Economy 🏗 - Wholesale inventories revision [Jul] ... 10a Running Hot 🔥 Gainers - Quotient Ltd [QTNT] >> +19.5% - MOGU Inc [MOGU] >> +37.3% - DocuSign [DOCU] >> +16.6% Decliners - ShiftPixy [PIXY] >> (14.7%) - Allakos Inc [ALLK] >> (20.5%) - Zumiez [ZUMZ] >> (14.1%) Charter Communications [CHTR] - Last Close: $395.91 Charter Communications is rebounding after hitting new lows. The broadband and cable company set a new 52-week low of $391.81 in Thursday's session, but shares began to bounce back after the closing bell. On Wednesday, Charter announced its intention to participate in an upcoming Goldman Sachs investor conference, and the news may have also played a role in today's rally. CHTR moved higher through the after-hours session and, now, it's one of the S&P 500's top premarket stocks. CHTR is up 3.2% in today's premarket. My Take: CHTR could be a good deal at this price. However, the stock is locked in a strong downtrend which could be hard to break. Its value stats look good, but short interest is high. InMed Pharmaceuticals [INM] - Last Close: $8.87 InMed Pharma is surging after a recent clinical update. Yesterday, the Vancouver-based pharma firm updated investors on its progress towards a pivotal drug trial. InMed CEO Eric Adams said the company plans to complete enrollment in a Phase 2 clinical program in epidermolysis bullosa by the end of the calendar year. Adams also said the firm will, "continue to advance a preclinical drug candidate in ocular disease and to investigate the utility of proprietary cannabinoid analogs in targeting specific diseases." The CEO also admitted that the timing of revenues from recently-acquired BayMedica's products is highly uncertain, and the company will evaluate whether the project is worth further investment. However, the company continues to explore the use of rare cannabinoids and their analogs to improve neural function and treat neurological disorders. Shares of INM are up 45.3% following the update, making it one of the day's top performers. My Take: It's unclear why this press release has sparked such a strong reaction in the stock. This tiny stock has declined steadily in 2022, but short interest is relatively tame at 1.0%. I don't know if this press release justifies this rally, so be cautious here. Digital Media Solutions [DMS] - Last Close: $1.28 News of a potential buyout deal is skyrocketing Digital Media Soutions. The digital marketing firm announced Thursday evening that it had received an all-cash acquisition offer from Prism Data. Under the terms of the deal, Prism will acquire all outstanding shares of DMS for $2.50 per share in cash. According to a company statement, DMS CEO Joseph Marinucci and COO Fernando Borghese are affiliated with the firm pursuing the deal. Upon closing, Prism Data plans to take Digital Media Solutions private. DMS is one of today's most active stocks, and it's up 60.9%. My Take: There's still potential upside in this trade because DMS hasn't declared whether it will accept the offer. If you think this deal will go through, you could get in at its current price point and ride the upside to $2.50. However, you could face sharp losses if the deal falls through. Swvl Holdings Corp [SWVL] - Last Close: $1.54 Swvl Holdings has officially landed itself on Wall Street's radar. Early this morning, Baird analyst Ben Kallo initiated coverage on the mass-transit ridesharing company with an "outperform" rating and a price target of $8. If he's right, the price target would represent a 419% gain from SWVL's Thursday closing price. Swvl also filed a Form 424B3 with the SEC this morning and disclosed plans to offer a "substantial percentage" of its Class A Ordinary Shares and Warrants will be offered for resale. SWVL is up 20.8% on highly active premarket trading volume. My Take: This tiny, unproven company has struggled since making its market debut in April. The analyst rating is promising, but price targets are often exaggerated. Be careful here because this stock could be very volatile. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](